API
< Back to situations

This situation has concluded

It was preserved as a record on September 4; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.

[SITUATION] · [QUIET] · [BUSINESS]

4 clusters · 47 sources · 9 days · First seen · Last updated

US talc litigation: J&J $5.5B settlement

Overview

U.S. courts continue to hear large talc lawsuits alleging asbestos in baby powder caused ovarian cancer and mesothelioma. A California jury awarded $966 million to a mesothelioma patient, and manufacturers have set aside roughly $9 billion for liability. The litigation prompted removal of talc baby‑powder from U.S. and Canadian markets in 2020; J&J stopped selling talc‑based baby powder in the United States in 2020 and worldwide in 2023.

Researchers have highlighted tumor risks from injectable contraceptives, linking long‑term high‑dose use to meningiomas, fueling calls for stronger safety standards for women’s products.

In July 2026 Johnson & Johnson announced a voluntary settlement valued at about $5.5 billion to resolve roughly 76,000 ovarian‑cancer claims. The plan requires at least 95 % of eligible claimants to accept; $3 billion would be paid in 2027 with the balance in 2028. J&J maintains its talc is asbestos‑free, does not admit liability, and its litigation vice‑president called the claims “baseless.” The settlement, negotiated outside bankruptcy court, covers only existing suits and would resolve the claims within 18‑24 months if the acceptance threshold is met.

Entities

Johnson & Johnson · Erik Haas · Chris Seeger · US federal courts · U.S. District Court for the District of New Jersey

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [BUSINESS] 3 sources
    Johnson & Johnson offers $5.5 billion settlement to end talc lawsuits

    Johnson & Johnson proposes a $5.5 billion settlement covering about 76,000 talc lawsuits, denying liability and awaiting approval from plaintiffs’ counsel.

  2. [BUSINESS] 11 sources
    Johnson & Johnson proposes $5.5 billion settlement to end talc cancer lawsuits

    Johnson & Johnson offers a $5.5 billion voluntary settlement covering ~76,000 U.S. ovarian‑cancer talc claims, requiring 95% claimant approval, with $3 billion due in 2027 and the rest in 2028.

  3. [BUSINESS] 32 sources
    Johnson & Johnson to Pay $5.5 B to Settle U.S. Talc Cancer Lawsuits

    Johnson & Johnson will pay about $5.5 billion to settle 76,000 U.S. talc lawsuits, pending 95% claimant approval; total payout may exceed $7 billion.

  4. [HEALTH] 2 sources
    US Talc Lawsuits and Birth‑Control Risks Highlight Women's Product Safety

    US courts award $966 million in a talc baby‑powder case and highlight ongoing lawsuits, while studies link injectable birth‑control to meningioma risk, prompting calls for stricter product safety.

Sources

ageas.com · atvbl.rs · bilkulonline.com · borsaefinanza.it · brasil.elpais.com · brasilemfolhas.com · cash.at · ct24.cz · dnyuz.com · euroweeklynews.com · fashionbiznes.pl · femtechworld.co.uk · finanse.wp.pl · folhadoprogresso.com.br · gamereactor.de · gamereactor.no · gamereactor.pl · gamereactor.se · ibtimes.com.au · insidefmcg.com.au · internewscast.com · it-boltwise.de · moj.powiat.pl · muzejrudarstvaimetalurgije.org · n1info.hr · ndmais.com.br · nenoticias.com.br · newswire.lk · nypost.com · op-online.de · orissapost.com · railwaysimulator.com · ratb.ro · sapo.pt · seucreditodigital.com.br · sokolovelaw.com · superbiz.se.pl · theartscouncil.com · thecurrent.pk · thefrontierpost.com · thethinkingconservative.com · usa.inquirer.net · usanews.net · vandringen.se · wiadomoscikosmetyczne.pl · wvfm1065.com · yovenice.com

This summary has been updated 7 times: see revision history